EB 382 - Names and Identifiers
EB 382 - Physico-chemical Properties
Molecular Formula | C13H17NO2
|
Molar Mass | 219.28 |
Density | 1.0697 (rough estimate) |
Melting Point | 107° |
Boling Point | 360.1°C (rough estimate) |
Solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) |
Appearance | Solid |
Color | Light Brown |
pKa | 4.86±0.50(Predicted) |
Storage Condition | -20°C Freezer |
Refractive Index | 1.5100 (estimate) |
In vitro study | Alminoprofen possesses a dual anti-inflammatory action, by inhibiting both sPLA2 but also COX-2. Alminoprofen (from 0 to 50 μM) induces a dose-related inhibitory response on thelevels of PGE2 formed by the CRL-1517 cell line. |
EB 382 - Risk and Safety
Toxicity | LD50 orally in mice: 2400 mg/kg (Dumaitre) |
EB 382 - References
biological activity | Alminoprofen is a non-steroidal anti-inflammatory drug (NSAID) of the phenylpropionic acid class. Alminoprofen has both secretory phospholipase A2 (sPLA2) activity and anti-cyclooxygenase (COX-2) activity. |
Animal Model:
| Groups of Wistar Rats (Oedema of the paw) |
Dosage:
| 100 mg/kg |
Administration:
| P.o. |
Result:
| Exerted a statistically significant dose-dependent antagonist action lasting throughout the 2-hr observation period. |
Last Update:2024-04-09 20:52:54